Stocks and Investing
Stocks and Investing
Tue, April 30, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kristen Kluska Reiterated (ATNM) at Buy and Held Target at $21 on, Apr 30th, 2024
Kristen Kluska of Cantor Fitzgerald, Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Buy and Held Target at $21 on, Apr 30th, 2024.
Kristen has made no other calls on ATNM in the last 4 months.
There are 2 other peers that have a rating on ATNM. Out of the 2 peers that are also analyzing ATNM, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kristen
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Monday, April 29th, 2024
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $30 on, Tuesday, March 19th, 2024
Contributing Sources